Data / Form D filings / Synvitrobio, Inc.
Synvitrobio, Inc.: Form D filing
Synvitrobio, Inc., a health care company in San Leandro, CA, filed a Form D with the SEC in 2023. The latest, on September 22, 2023, reports $17.6 million sold of a $17.6 million offering to 16 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1933 DAVIS STREET, SUITE 223, San Leandro, CA, 94577
- Phone
- (510) 352-8600
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1994409
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 22, 2023 | New notice | $17,556,003 | $17,556,003 | 16 | Sep 8, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Nemzek | Executive Officer, Director | |
| Francisco Dopazo | Director | |
| Zachary Sun | Executive Officer, Director | |
| Corinna Chen | Director |
Other health care companies in California that filed recently
- VERIONYX, INC. offering · Oct 26, 2026
- RCE Technologies, Inc. $110,000 · Oct 23, 2026
- Gale Force Aesthetics, Inc. $800,000 · Oct 22, 2026
- VahatiCor, Inc. $30.4 million · Oct 20, 2026
- Lamina Surgical, Inc. $490,000 · Oct 16, 2026
- Ellipsys Medical, Inc. $8.6 million · Oct 14, 2026
Every Form D from the week of Sep 18, 2023 · All recent filings in California · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Synvitrobio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.